Author

Rishi Jain

Northwestern UniversityORCID 0000-0003-4459-5504Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Rishi Jain1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Adam M. SonabendiD· 1 shared Andrew GouldiD· 1 shared Bin ZhangiD· 1 shared Catalina Lee-ChangiD· 1 shared Crismita DmelloiD· 1 shared Daniel Levey· 1 shared Dhan Sidhartha ChandiD· 1 shared Dieter Henrik HeilandiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam M. SonabendORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedJun 25, 2026

MAPK/ERK signaling in gliomas modulates interferon responses, T cell recruitment, enhances tumor-microglia crosstalk, and drives immune checkpoint blockade efficacy.

Kwang‐Soo Kim, Junyi Zhang, Victor Andrés Arrieta…·Adam M. Sonabend

This study identifies the MAPK/ERK pathway as a key regulator of glioma susceptibility to immune checkpoint blockade, showing it modulates interferon responses, T cell recruitment, and tumor-microglia interactions.

8 citationstop 1%

𝕏 PostBluesky